bendamustine
Also known as Levact®, SDX-105, Treanda®, Ribomustine
Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.
Chemical data
- Formula
- C16H21Cl2N3O2
- Molecular weight
- 358.3 g/mol
- IUPAC name
- 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
- SMILES
- CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O
- InChIKey
- YTKUWDBFDASYHO-UHFFFAOYSA-N
- XLogP
- 2.9
- Polar surface area
- 58.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Article
6 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- History
- Research
- References
Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.
Common side effects include low blood cell counts, fever, nausea, diarrhea, loss of appetite, cough, and rash. Other severe side effects include allergic reactions and increased risk of infection. Use in pregnancy is known to harm the baby. Bendamustine is in the alkylating agents drug class. It works by interfering with the function of DNA and RNA.